Understanding how social determinants of health influence pain experiences is crucial for advancing pain management. The NIH HEAL Initiative, supported by the National Institute on Minority Health and Health Disparities (NIMHD), is leading the charge to address health disparities in pain management through inclusive clinical research.  Clinical trials play a vital role in improving human health, relying on the participation of diverse patients to explore effective pain management strategies. To learn more about HEAL-funded pain management trials and see if you might be eligible to participate, visit the NIH HEAL-Funded Pain Management Clinical Trials webpage. Explore these trials and see

The National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), has revealed its updated priorities for research on mpox. This initiative is intended to enhance our comprehension of the virus and improve methods for detection, treatment, and prevention. Key Objectives: 1. Virus Biology: Increase understanding of all mpox virus clades, including transmission and immune system responses. 2. Vaccine Development: Evaluate the current vaccine dosing regimens and develop new vaccine concepts to optimize the supply. 3. Treatment Advancement: Improve existing treatments and develop novel approaches, including antivirals and monoclonal antibodies. 4. Detection Strategies: Support

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.

To view the entire newsletter click the image below.